发明名称 Partial mGluR5 antagonists for treatment of anxiety and CNS disorders
摘要 Provided is a method of treating conditions and disorders for which full mGluR5 antagonists are potentially effective, such as, e.g., anxiety, epilepsy, schizophrenia and other psychotic disorders, Parkinson's disease, addictive disorders, and the like in a subject in need of such treatment, comprising administration to such subject of a therapeutically effective amount of a partial, non-competitive mGluR5 antagonist compound of the invention. Specific examples of partial MgluR5 antagonists provided include those compounds having the formula: wherein: Z is, independently N or -CH-, provided that one, and only one Z is N; R is halogen (e.g., Br, F and the like), alkyl (e.g., methyl), alkenyl (e.g., CH-CH2, aryl (e.g., phenyl), heterocyclic (e.g., thiophenyl).
申请公布号 US7531541(B2) 申请公布日期 2009.05.12
申请号 US20060523873 申请日期 2006.09.20
申请人 VANDERBILT UNIVERSITY 发明人 CONN P. JEFFREY;RODRIGUEZ ALICE L.;JONES CARRIE K.
分类号 A61K31/497;C07D239/42 主分类号 A61K31/497
代理机构 代理人
主权项
地址